RECURSION PHARMACEUTICALS, INC. RXRX 深 滬
等待開盤 09-20 09:30:00 美东时间
6.94
+0.030
+0.43%
華盛通- 最 高7.24
- 今 開7.16
- 成交量 463.43万股
- 最 低 6.90
- 昨 收 6.91
- 總市值 16.31亿
- 52周最高 15.74
- 市盈率 靜 --
- 換手率 1.97%
- 52周最低 4.97
- 委 比 -78.77%
- 總股本 2.35亿
- 歷史最高 42.81
- 量 比 1.13
- 振 幅 4.92%
- 歷史最低 4.54
- 每 手 1
- 風險率 1.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Looking Into Recursion Pharmaceuticals's Recent Short Interest
Recursion Pharmaceuticals's (NYSE:RXRX) short percent of float has risen 11.25%...
09-17 03:00
Recursion posts mid-stage data for lead asset
Recursion Pharmaceuticals (NASDAQ:RXRX) on Tuesday announced topline results from its SYCAMORE Phase 2 trial for its most advanced candidate REC-994 in symptomatic cerebral cavernous malformation (CCM...
09-03 20:43
Recursion Pharmaceuticals Proposes Strategic Exscientia Merger
Recursion Pharmaceuticals (RXRX) has shared an update. Recursion Pharmaceutical...
09-03 20:28
How Is The Market Feeling About Recursion Pharmaceuticals?
Recursion Pharmaceuticals's (NYSE:RXRX) short percent of float has fallen 4.97%...
08-23 22:00
6.88亿美元！英伟达投资的AI新药公司拟收购其竞争对手
8月8日，利用人工智能发现新药的生物科技公司Recursion Pharmaceuticals (RXRX.O)已同意收购规模较小的竞争...
08-12 10:11
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXRX, GVP, OBDE on Behalf of Shareholders
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
08-10 03:05
快讯 | Recursion Pharmaceuticals公司：Needham将目标价从17美元下调至16美元
Recursion Pharmaceuticals Inc : Needham Cuts Target Price to $16 From $17
08-09 20:01
Needham Maintains Buy on Recursion Pharmaceuticals, Lowers Price Target to $16
Needham analyst Gil Blum maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with...
08-09 19:57
Recursion Pharmaceuticals Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-09 19:55
